Nuero Flashcards
Dextrose
Classification
Carbohydrate
MOA
Caloric supplement in patients who can’t maintain adequate oral intake. Raises the sugar level
Indications
Low blood sugar
Contraindications
Hypersensitivity, corn allergy, interspinal bleed intracranial bleed
Dosage/ Route of administration
12.5-25g slow IV push
Diazepam / Valium
Classification
Benzodiazepine
MOA
Binds to the GABA receptor to reduce arousal and affects emotions. Raises threshold for seizures
Indications
Acute anxiety, muscle relaxation, seizures,Sedation for RSI
Contraindications
Hypersensitivity, Myasthenia Gravis, Respiratory insufficiency, Coma, Head injury
Dosage:
5-10 mg max of 30 mg IV seizure
5-15 mg IV over 10 to 15 mins prior to cardioversion sedation/ RSI
Fentanyl / Sublimaze
Classification
Narcotic
MOA
Stimulates opioid receptors in the brain to create an analgesic effect and also binds to the kappa receptors. Used for pain management, RSI sedation, also used as a general anesthetic
Indications
Pain management, RSI sedation
Contraindications
Hypersensitivity, shock, respiratory depression, less than 2 years old
Cautions
50 to 100 times more powerful than morphine can absorb through the skin, drug is abused frequently
Dosage
Pain management 1 mcg/kg up to 300 mcg IM, IV, IO
RSI sedation 2-5 mcg/kg
Ketamine / Ketalar
Classification
Anesthetic, Sedative
MOA
Antagonist for the N-methyl-D aspartate receptor found in the nerve
Indications
RSI sedation, pain management, behavioral emergencies, surgical sedation
Contraindications
Hypersensitivity, Severe HTN, intracranial mass, depression, glaucoma, hypertension, tachycardia, thyroid disorder, coronary artery disease
Dosage
Behavioral emergency 4 mg/kg IM up to 400mg
Pain management IV/IO 0.1- 0.2 mg/kg IV/IO diluted in equal volume of saline 20 mg max
Pain management IM/IN 0.4 - 0.8 mg/kg IM/IN 40-60mg max
RSI sedation 1 to 2 mg/kg IV/ 3-8 mg/kg IM
Maintenance dose 0.1 to 0.5 mg/min
ketorolac / Toradol
Classification
Anti-inflammatory, Non-steroidal
MOA
An anti-inflammatory non-narcotic analgesic by inhibiting prostaglandin synthesis used for pain management
Indications
Pain management,Sedation
Contraindications
Peptic ulcer disease, gastrointestinal bleeding, labor and delivery, advance renal impairment, nursing mothers, hypersensitivity, cerebrovascular bleeding
Dosage/ Route of administration
30 mg IM
15 mg slow IV
Lidocaine / Xylocaine
Classification
Anesthetic, Antiarrhythmic
MOA
Sodium channel blocker increases depolarization recovery period suppresses automaticity and depolarization of ventricles
Indication
Cardiac arrest, ventricular arrhythmias, MI, Cardioversion, digital poisoning
Contraindication
Hypersensitivity, AV node block, adam stokes syndrome. Wolff parkinson white syndrome
Dosage/ Route of administration
Px mgmt for IO: 40 mg SIVP
Pulsless VT: 0.5mg /kg up to 1.5 mg/kg every 5-10 min to a MAX 3 mg/kg
Maintenance dose: 1-4 mcg/min IV 1 g in 250 ml D5W or NS
Lorazepam / Ativan
Classification
Benzodiazepine
MOA
binds GABA receptors decreasing cerebral irritability, sedation, & stops generalized seizures
Indication
Status Epilepticus, anxiety relief, Delirium tremens
Contraindication
Hypersensitivity, respiratory impairment, hypotension, shock
Side effects
Fatigue, drowsiness, amnesia, confusion, disorientation, euphoria
Untoward effects
Respiratory depression, coma, nausea, jaundice, unsteadiness
Dosage/ Route of administration
2-4 mg IV diluted in an equal volume of saline
Midazolam / Versed
Classification
Sedative
MOA
Binds to the GABA receptor acting as short cns depressant, calming & relaxing the skeletal muscle and inducing sleep, which can be used to help with seizures
Indications
pre-cardioversion, seizure control, sedation post intubation, anxiolysis, amnesia
Contraindications
Hypersensitivity, respiratory arrest and difficulty, chronic heart failure, coma shock acute renal failure, hypotension
Dosage
RSI sedation 0.1-0.3 mg/kg max of 10 mg
Infusion 0.5 mg/ml Bolus 0.01-0.05 mg/kg
Maintenance 1-7 mg/hour
Behavioral 1-2.5 mg slow IV push
Seizure 2-6 mg IV,IM,IO
Morphine / Duramorph
Classification
Opioid, narcotic
MOA
Binds to the opioid receptor directly affects the central nervous system to decrease the feeling of pain used for pain management
Indications
Pain management
Contraindications
Hypersensitivity Respiratory insufficiency, head injuries, increased intracranial pressure,
Side effects
Abdominal pain, blurred vision, nausea, vomiting, cough, fainting, decreased urination
Untoward effects
Chest pain, irregular heart rate, nervousness, bradycardia, pounding in the ears
Dosage/ Route of administration
0.1 mg/kg max of 10 mg
Ibuprofen / Advil
Classification
Analgesic, non-steroidal anti inflammatory
MOA
Anti inflammatory and antipyretic reversible inhibitor of COX 1 and COX 2
Indication
Fever, Moderate pain, Kidney pain, swelling
Contraindication
Hypersensitivity, asthma, urticaria, idiosyncratic, peptic ulcer, active GI bleed
Side effects
Upset stomach, heartburn, nausea, vomiting, bloating, gas, diarrhea, nervousness,
Untoward effect
Ringing in the ears, changes in vision, slurred speech, coughing up blood, shortness of breath
Dosage/ Route of administration
300-800 mg PO
Acetaminophen / Tylenol
Classification
Non-narcotic, analgesic, Antipyretic
MOA
Antipyretic Activity, Analgesic Activity - Inhibition of central & peripheral prostaglandin synthesis
indications
Fever, pain
Contraindications
Hypersensitivity
Side effects
Drowsiness, nausea, vomiting, itching, rash
Untoward effects
Dark urine, jaundice, abdominal pain, trouble breathing, severe dizziness
Dosage/ Route of indication
325-1000 mg PO, PR